Zimbabwe

in page functions
[French]
Zimbabwe
Total population (2017) 16,337,657
Birth cohort (2017) 537,364
Surviving Infants (surviving to 1 year per year, 2017) 515,965
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 47/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 71/1000
World Bank Index, IDA (2015) 2.86
Gross Nation Income (per capita US$, 2015) 860
Co-financing group (2017) Initial self-financing
No. of districts/territories (2015) 63
Download this page as a PDF factsheet

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Zimbabwe

Type of support

Approvals

2001-2021 (US$)
(29 Jun 2017)

Commitments

2001-2021 (US$)
(29 Jun 2017)

Disbursements

2000-2017 (US$)
(29 Jun 2017)

% Disbursed

(29 Jun 2017)
 2001 2002 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Total $91,623,900 $108,550,400 $93,143,697
Cash support (CASHSUPP) $170,000 $195,000 $170,000 100%
Health system strengthening (HSS 1) $6,546,827 $6,546,827 $6,546,827 100%
HPV Demo (NVS) $241,086 $241,086 $241,773 100%
Immunisation services support (ISS) $1,564,006 $1,564,006 $1,564,006 100%
Injection Safety Devices (NVS) $141,000 $439,000 $178,441 127%
Injection safety support (INS) $948,925 $948,925 $948,925 100%
IPV (NVS) $53,783 $53,783 $37,259 69%
Measles (NVS) $441,500 $441,500 $64,362 15%
Measles-Rubella (NVS) $3,785,235 $3,785,235 $3,785,235 100%
MR - Operational costs (OPC) $3,422,500 $3,422,500 $3,422,500 100%
Penta (NVS) $28,619,889 $31,584,389 $28,404,387 99%
Pneumo (NVS) $36,217,097 $45,987,097 $38,400,202 106%
Rotavirus (NVS) $7,741,052 $11,610,052 $7,648,780 99%
Vaccine Introduction Grant (VIG) $1,731,000 $1,731,000 $1,731,000 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Zimbabwe DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2015)

Grade of confidence

N/A
DTP3 - Official country estimates (2015) 96%
M:F sex ratio at birth (2017) 1.02
Household survey: DTP3 coverage for male (2013) 87.40%
Household survey: DTP3 coverage for female (2013) 87.20%
Household survey: Last DTP3 survey (2013) 87%
% districts achieving > 80% DTP3 coverage (2015) 68%
% districts achieving < 50% DTP3 coverage (2015) 0%
MCV WHO/UNICEF estimates (2015) 86%

Breakdown of support

Non-vaccine support Vaccine support
15% 85%
$14,383,258 $78,760,439

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Zimbabwe

17 July 2015

India pentavalent scale-up 2014

New coverage figures show more children than ever being reached with immunisation in poorest countries

Coverage trends heading in right direction but major differences remain between countries.

10 January 2013

mopan

GAVI recognised for effectiveness and focus on results

In its first ever Multilateral Organisation Performance Assessment Network (MOPAN) review the GAVI Alliance has been commended for its effectiveness in increasing access to immunisation and for its focus on results.

28 November 2012

IFFIm6_GAVI_07_Edy_Purnomo_Indonesia_700F

29 – The new new vaccines: what vaccines could be coming your way in the next 5-7 years?

Partners Forum 2012 - Session summary. Speakers presented the status of several vaccines that are priorities in many developing countries, such as HIV and TB, and discussed the status of two vaccines which the GAVI Board has already indicated specific interest in: malaria and cholera.

Useful links

View all sources for data in this page
close icon

modal window here